News
Accord and ADIENNE Enter into Exclusive Distribution Agreement for TEPADINA®
London, England and Lugano, Switzerland 19 November 2019 – Accord Healthcare Limited (“Accord”) and ADIENNE Pharma & Biotech S.A. (“ADIENNE”) have entered into an exclusive licencing and distribution agreement for the commercialisation of TEPADINA® (thiotepa) 15mg and 100mg lyophilized powder for injections.
Healthcare – the most recognised company at the Global Generics & Biosimilar Awards 2018
We are delighted to announce that Accord Healthcare was the most recognised company at the Global
Accord Healthcare gewinnt in 3 Kategorien der Global Generics & Biosimilars Awards 2017
Accord Healthcare war bei den diesjährigen Global Generics & Biosimilars Awards am 23. Oktober 2017 gleich in mehreren Kategorien in der engeren Auswahl.
INTAS COMPLETES DEAL
Intas Pharmaceuticals completes deal to acquire Actavis UK & Ireland generics businesses.